On January 27, the World Health Organization (WHO) updated its official website with a list of recommended drug stockpiles for "radiological and nuclear emergencies".

The typical radiation emergency stockpile mentioned in this list includes the following drugs.
Stabilized iodine (potassium iodide): used to stop or reduce the absorption of radioactive iodine by the thyroid gland.
Prussian blue: used to remove radioactive cesium (Cs) and thallium (Tl) from inside the body.
Cytokines used to alleviate bone marrow damage in the case of acute radiation syndrome (ARS).
Other drugs used to treat vomiting, diarrhea and infections.
Of these, Prussian blue is relatively unknown to clinicians. Pharmachem will summarize the drug insert for Prussian Blue, detailing the drug's indications, dosing instructions, and medication adjustments for special populations.

I. Foreign indications, dosage and administration
Orphan drug designation: for the treatment of patients with known or suspected radioactive or non-radioactive cesium or thallium-induced internal contamination.

II. Precautions
Endocrine system and metabolism: Hypokalemia has been reported. Monitoring of blood potassium is required, especially in patients with pre-existing cardiac arrhythmias or electrolyte disturbances.

III. Medication for special populations
Pediatric Dosage.
For the treatment of patients with known or suspected radioactive or non-radioactive cesium or thallium-induced internal contamination.